No.1003/2021-2022
Aizawl, the 17th June 2021 : Principal Chief Executive Officer, Mizoram State Health Care Society chuan cancer enkawlna damdawi man tlawn thlanchhuah leh hemi kaihhnawih a Medical Reimbursement chungchangah a hnuai ami angin vawiin khan Press Note a chhuah.
Mizoram State Cancer Institute (MSCI) Indoor Pharmacy, Administrative Building, Zemabawk ah Cancer enkawlna damdawi man tlawm lei theih a ni ta. District Hospital leh damdawiin dangten an mamawh dan angin MSCI aṭangin an la chhawng thei bawk ang. Mimal damdawi zuarah erawh chuan heng damdawi man tlawmte hi zawrh chhuah a ni hrih dawnlo a ni.
Finance Department Notification No.D.12015/1/2018 – FEA dated 21st May, 2021 angin Sawrkar hnathawk MR, Health Care Scheme leh AB PM-JAY-ah te hian Cancer enkawlna damdawi man tlawm rate ang chauh zelin inenkawlna senso (medical reimbursement claims)-te chu approve tawh tur a ni. Hei hian Cancer enkawlna damdawi chi 47 leh Albumin infusion a huam ang, heng baka inenkawlna damdawi erawh chu a rate pangngai angin approve a ni ang. Rate tlawm mila bill approve hi July, 2021 china inenkawlna bill turte ah hman ṭan a ni dawn a ni.
Heng damdawite hi Mizoram-a kan hman ṭhan Company ṭha leh rintlaka ngaihte hnen aṭanga man tlawm zawka mipuite lei theih tura chah chhuah a ni a. A lei duh tan Mizoram State Cancer Institute Indoor Pharmacy, Administrative Building, Zemabawk, Aizawl-ah ngaihven tur a ni e.
Cancer enkawlna damdawi man tlawm rate mila Sawrkar hnathawk MR,Health Care Schemeleh AB PM-JAY bill pek chhuah kawngah Sawrkar damdawiin leh Private damdawiin in danglamna a neilo.
Cancer Damdawi man tlawmte chu heng a hnuaia tarlante hi an ni e:
SN | Name of Drug | Dose | Formulation | SN | Name of Drug | Dose | Formulation | |
1 | AFATINIB | 30 mg | TAB | 24 | OLAPARIB | 150mg | TAB | |
2 | ANASTRAZOLE | 1 mg | TAB | 25 | CAPECITABINE | 500 mg | TAB | |
3 | AZACITIDINE | 100 mg | INJ | 26 | DOCETAXEL | 20 mg | INJ | |
4 | IMATINIB | 400 mg | TAB | 27 | DOCETAXEL | 80 mg | INJ | |
5 | SORAFENIB | 200 mg | TAB | 28 | DOCETAXEL | 120 mg | INJ | |
6 | ERLOTINIB | 150 mg | TAB | 29 | DOXORUBICIN | 10 mg | INJ | |
7 | ZOLEDRONIC ACID | 4 mg | INJ | 30 | DOXORUBICIN | 50 mg | INJ | |
8 | APREPITANT | 125 mg | CAP | 31 | EPIRUBICIN | 10 mg | INJ | |
9 | BOSUTINIB | 100 mg | TAB | 32 | EPIRUBICIN | 50 mg | INJ | |
10 | BOSUTINIB | 400 mg | TAB | 33 | EPIRUBICIN | 100 mg | INJ | |
11 | CARBOPLATIN | 150 mg | INJ | 34 | ETOPOSIDE | 50 mg | CAP | |
12 | CARBOPLATIN | 450 mg | INJ | 35 | GEFITINIB | 250 mg | TAB | |
13 | CYTARABINE | 1 gm | INJ | 36 | GEMCITABINE | 200 mg | INJ | |
14 | IRINOTECAN | 40 mg | INJ | 37 | GEMCITABINE | 1 gm | INJ | |
15 | IRINOTECAN | 100 mg | INJ | 38 | LEUCOVORIN | 50 mg | INJ | |
16 | VINORELBINE | 50 mg | INJ | 39 | OXALIPLATIN | 50 mg | INJ | |
17 | PEG FILGRASTIM | 6 mg | INJ | 40 | OXALIPLATIN | 100 mg | INJ | |
18 | BEVACIZUMAB | 100 mg | INJ | 41 | PACLITAXEL | 30 mg | INJ | |
19 | BEVACIZUMAB | 400 mg | INJ | 42 | PACLITAXEL | 100 mg | INJ | |
20 | RITUXIMAB | 100 mg | INJ | 43 | PACLITAXEL | 260 mg | INJ | |
21 | RITUXIMAB | 500 mg | INJ | 44 | PACLITAXEL | 300 mg | INJ | |
22 | TRASTUZUMAB | 440 mg | INJ | 45 | PEMETREXED | 100 mg | INJ | |
23 | FILGRASTIM | 300 mcg | INJ | 46 | PEMETREXED | 500 mg | INJ | |
24 | OLAPARIB | 150mg | TAB | 47 | PALBOCICLIB | 125 mg | TAB | |
25 | CAPECITABINE | 500 mg | TAB | 48 | HUMAN ALBUMIN 20% | 100 ml | INF |
